Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019

article

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2807/1560-7917.ES.2019.24.4.1900055
P932PMC publication ID6351998
P698PubMed publication ID30696523

P50authorMel KrajdenQ6810759
Gaston De SerresQ86870133
Jonathan B GubbayQ87716515
Danuta M. SkowronskiQ111259505
Romy OlshaQ114718263
Suzana SabaiducQ114718265
Tracy ChanQ114718286
Siobhan LeirQ114718287
James A DickinsonQ42422634
Matthew A CroxenQ56491447
Michelle MurtiQ60313150
Yan LiQ69032212
Nathalie BastienQ69032280
Hugues CharestQ86870110
P2860cites workDiversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.Q27320929
The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin.Q30329363
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret modelQ30430458
Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic propertiesQ34055754
Selection of antigenically advanced variants of seasonal influenza virusesQ36116332
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza SeasonQ38415770
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studiesQ38803189
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.Q39884414
Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.Q42237299
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in CanadaQ47613621
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.Q49204982
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectCanadaQ16
vaccine-preventable diseasesQ7907939
P577publication date2019-01-01
P1433published inEurosurveillanceQ14565070
P1476titleInterim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
P478volume24

Reverse relations

cites work (P2860)
Q91761667A case of reassortant seasonal influenza A(H1N2) virus, Denmark, April 2019
Q92706811A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy)
Q89655390Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene
Q64054477Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic
Q64087276Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019
Q64271987Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19
Q94662614Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019
Q92942088Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019
Q91636311Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria
Q92732609Intense interseasonal influenza outbreaks, Australia, 2018/19
Q64118690Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Q64243916Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019
Q89881062Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
Q64087253Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019
Q97092978Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019
Q90948756Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19
Q91724850Should individuals use influenza vaccine effectiveness studies to inform their decision to get vaccinated?